From the AP-HP, Diagnostic and Therapeutic Center, Paris Descartes University, Hôtel-Dieu, France (M.E.S., J.-B.G., S.A.B., A.Y.); Centre d'investigations préventives et cliniques (IPC), Paris, France (F.T.); and Lebanese American University Medical Center-Rizk Hospital, Beirut, Lebanon (S.A.B.).
Hypertension. 2017 Jun;69(6):1029-1035. doi: 10.1161/HYPERTENSIONAHA.116.08962. Epub 2017 Apr 10.
Despite adequate glycemic and blood pressure control, treated type 2 diabetic hypertensive subjects have a significantly elevated overall/cardiovascular risk. We studied 244 816 normotensive and 99 720 hypertensive subjects (including 7480 type 2 diabetics) attending medical checkups between 1992 and 2011. We sought to identify significant differences in overall/cardiovascular risk between hypertension with and without diabetes mellitus. Mean follow-up was 12.7 years; 14 050 all-cause deaths were reported. From normotensive to hypertensive populations, a significant progression in overall/cardiovascular mortality was observed. Mortality was significantly greater among diabetic than nondiabetic hypertensive subjects (all-cause mortality, 14.05% versus 7.43%; and cardiovascular mortality, 1.28% versus 0.7%). No interaction was observed between hemodynamic measurements and overall/cardiovascular risk, suggesting that blood pressure factors, even during drug therapy, could not explain the differences in mortality rates between diabetic and nondiabetic hypertensive patients. Using cross-sectional regression models, a significant association was observed between higher education levels, lower levels of anxiety and depression, and reduced overall mortality in diabetic hypertensive subjects, while impaired renal function, a history of stroke and myocardial infarction, and increased alcohol and tobacco consumption were significantly associated with increased mortality. Blood pressure and glycemic control alone cannot reverse overall/cardiovascular risk in diabetics with hypertension. Together with cardiovascular measures, overall prevention should include recommendations to reduce alcohol and tobacco consumption and improve stress, education levels, and physical activity.
尽管血糖和血压得到了充分控制,接受治疗的 2 型糖尿病高血压患者的总体/心血管风险仍显著升高。我们研究了 1992 年至 2011 年间参加体检的 244816 名血压正常和 99720 名高血压患者(包括 7480 名 2 型糖尿病患者)。我们试图确定高血压合并和不合并糖尿病患者的总体/心血管风险之间是否存在显著差异。平均随访时间为 12.7 年;报告了 14050 例全因死亡。从血压正常人群到高血压人群,观察到总体/心血管死亡率显著增加。与非糖尿病高血压患者相比,糖尿病患者的死亡率明显更高(全因死亡率为 14.05%对 7.43%;心血管死亡率为 1.28%对 0.7%)。在血压和总体/心血管风险之间未观察到交互作用,这表明即使在药物治疗期间,血压因素也不能解释糖尿病和非糖尿病高血压患者之间的死亡率差异。使用横断面回归模型,观察到在糖尿病高血压患者中,较高的教育水平、较低的焦虑和抑郁水平与总体死亡率降低之间存在显著相关性,而肾功能受损、中风和心肌梗死史以及饮酒和吸烟增加与死亡率增加显著相关。单独控制血压和血糖并不能逆转高血压合并糖尿病患者的总体/心血管风险。除了心血管措施外,总体预防还应包括减少饮酒和吸烟以及改善压力、教育水平和体育活动的建议。